Category: Pharma & drug development

Pharma & drug development

Understanding drug-resistant TB

Pharma & drug development

How do cancer cells communicate and can it help us catch them?

Pharma & drug development

Proteomics and the promise of ‘enriching’ clinical trials

Pharma & drug development

Is growth factor protein the future of Parkinson’s treatment?

Mental health Pharma & drug development

The drugs fighting memory loss

Pharma & drug development War on drugs

Medical cannabis in the UK: how has the roll out gone so far?

Pharma & drug development War on drugs

Thumbs up for esketamine

Pharma & drug development

Access to antivenom needs attention

Pharma & drug development

Developing a new class of cancer combo drugs

Pharma & drug development

Is a lack of female participants skewing heart disease trial results?

Pharma & drug development Science & tech

Using AI to personalise drug combination therapy

Pharma & drug development

Manufacturing personalised meds: what needs to change?

Pharma & drug development

Gene and cell therapies: making manufacturing work

Pharma & drug development Science & tech

Disposable diagnostics

Pharma & drug development

Philanthropy in pharma: a look inside the ISPE Foundation

Pharma & drug development

The next generation of antimalarials

Pharma & drug development

Could cutting out mediators let cancer research off the leash?

Pharma & drug development War on drugs

Cannabinoids breakthrough signals hope for epilepsy treatment

Pharma & drug development

Paying the bill for innovative gene and cell therapies

Pharma & drug development War on drugs

Immunising against opioids